Trial of VELCADE and Rituxan as Front-line Tx for Low-grade NHL

Clinical trial NCT00369707 · COMPLETED

Trial details

NCT number: NCT00369707
Sponsor: Northwestern University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma

Start date: 2006-08-09
Primary completion: 2012-05-22
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.